Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Elevation Oncology announce a Phase 2 trial for EO-3021 by March 31, 2025?  | Binary | 4 | 5 months ago | ||
Will EO-3021 achieve an ORR greater than 40% in dose expansion phase by end of 2024? | Binary | 3 | 5 months ago | ||
Will Elevation Oncology's stock price recover to pre-announcement levels by end of 2024? | Binary | 3 | 5 months ago | ||
How will Elevation Oncology's stock price change by end of 2024? | Categorical | 3 | 5 months ago | ||
What will be EO-3021's ORR in dose expansion phase by end of 2024? | Categorical | 2 | 5 months ago | ||
What will be the most common side effect observed in EO-3021 dose expansion phase by end of 2024? | Categorical | 2 | 5 months ago |